Investment Thesis
Welltower demonstrates solid operational fundamentals with strong 28.2% revenue growth and excellent free cash flow conversion (26.6% FCF margin), supported by a healthy balance sheet with 0.46x debt-to-equity ratio. While profitability metrics show pressure (net margin 8.6%, ROE 2.2%), the substantial $2.9B operating cash flow and conservative leverage position the company well for continued dividend support and capital deployment.
WELL Strengths
- Strong revenue growth of 28.2% year-over-year demonstrates operational momentum
- Excellent free cash flow margin of 26.6% with $2.9B FCF supports sustainability
- Conservative capital structure with 0.46x debt-to-equity and $5.0B cash position
- Substantial $67.3B asset base provides diversified healthcare real estate portfolio
WELL Risks
- Low return metrics (ROE 2.2%, ROA 1.4%) indicate capital efficiency challenges
- Diluted EPS declined 11.5% despite revenue growth, signaling margin compression
- Net income declined 2.6% year-over-year despite 28.2% revenue growth, raising operational concerns
- Real estate sector sensitivity to interest rate environment and occupancy rates
Key Metrics to Watch
- Operating cash flow trends and free cash flow consistency
- Net margin recovery and diluted EPS trajectory
- Debt levels and interest coverage ratio in changing rate environment
- Same-property NOI growth and portfolio occupancy rates
WELL Financial Metrics
WELL Profitability Ratios
WELL Balance Sheet & Liquidity
WELL 5-Year Financial Trend
5-Year Trend Summary: WELLTOWER INC.'s revenue has grown significantly by 78% over the 5-year period, indicating strong business expansion. The most recent EPS of $0.66 reflects profitable operations.
WELL Growth Metrics (YoY)
WELL Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $1.5B | $282.2M | $0.41 |
| Q2 2025 | $1.4B | $260.7M | $0.42 |
| Q1 2025 | $1.4B | $131.6M | $0.22 |
| Q3 2024 | $1.2B | $134.7M | $0.24 |
| Q2 2024 | $1.2B | $106.3M | $0.20 |
| Q1 2024 | $1.1B | $28.6M | $0.05 |
| Q3 2018 | $1.1B | $84.2M | $0.17 |
| Q2 2018 | $1.1B | $167.3M | $0.41 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
WELL Capital Allocation
WELL SEC Filings
Access official SEC EDGAR filings for WELLTOWER INC. (CIK: 0000766704)